European Respiratory Society

Progress in precision medicine in cystic fibrosis
The current issue of Breathe includes a review of progress in precision medicine in cystic fibrosis, with a focus on CFTR modulator drugs that target the underlying cellular defect in cystic fibrosis
Precision medicine in bronchiectasis
The latest issue of Breathe includes a review looking at the importance of personalising treatments of bronchiectasis. The authors discuss the tests are required to identify the underlying causes bronchiectasis and how to target specific treatments.
The latest from ERS on SARS-CoV-2 and COVID-19
ERS has created a page bringing together all its SARS-CoV-2 and COVID-19 resources for professionals, including webinars, patient resources and publications
Use of treatable traits to address COPD complexity and heterogeneity
The current issue of Breathe includes a review that examines the use of a treatable traits strategy as a tool for the diagnosis and management of patients with COPD, to allow implementation of precision medicine in chronic airway diseases
Myths and maxims in paediatric respiratory medicine
Breathe is running a series of articles focusing on myths and maxims in paediatric respiratory medicine

Targeted therapy in respiratory disease

The latest issue of Breathe focuses on targeted therapies in respiratory disease, with articles looking individualised care in bronchiectasis and selection of therapies for patients with CTD-related ILD.

The Early career forum provides a preview of the ERS Lung Science Conference 2022.

Read the introductory editorial from Chief Editor Brian Kent.

Browse the full table of contents

Latest Articles

A young man with transitory hemiparesis and lung infiltrates
Anja Ljilja, Niko Radović, Jasna Tekavec-Trkanjec

Breathe Dec 2021, 17 (4) 210069; DOI: 10.1183/20734735.0069-2021
The use of treatable traits to address COPD complexity and heterogeneity and to inform the care
Katarzyna Duszyk, Rebecca F. McLoughlin, Peter G. Gibson, Vanessa M. McDonald

Breathe Dec 2021, 17 (4) 210118; DOI: 10.1183/20734735.0118-2021
Contribution of causal factors to disease burden: how to interpret attributable fractions
Emilie Counil

Breathe Dec 2021, 17 (4) 210086; DOI: 10.1183/20734735.0086-2021
Progress in precision medicine in cystic fibrosis: a focus on CFTR modulator therapy
Daniel H. Tewkesbury, Rebecca C. Robey, Peter J. Barry

Breathe Dec 2021, 17 (4) 210112; DOI: 10.1183/20734735.0112-2021
First report of a very rare complication in a case of nonsmall cell lung carcinoma
Inês Moreira, Ana Sofia Vilariça, Paula Alves

Breathe Dec 2021, 17 (4) 210107; DOI: 10.1183/20734735.0107-2021
Stating the obvious: intravenous magnesium sulphate should be the first parenteral bronchodilator in paediatric asthma exacerbations unresponsive to first-line therapy
Gokul Erumbala, Sabu Anzar, Amjad Tonbari, Ramadan Salem, Colin Powell

Breathe Dec 2021, 17 (4) 210113; DOI: 10.1183/20734735.0113-2021

About Breathe

Breathe is the clinical educational publication from the European Respiratory Society. It is published quarterly and is free to access for all in order to bring high-quality educational material to a wide audience.

More...

Main menu

User menu

Search

Latest Articles

About Breathe

Contact us